Ontex reported revenue of €962.6 million ($1.05 billion), up 12.9%, for H1 2016. Adjusted net profit was €65.7 million ($72.2 million), up 11% compared to last year. Second quarter revenue was €510.2 million ($561.1 million), a yoy increase of 19.3%.

Charles Bouaziz, Ontex CEO, comments: “We demonstrated our resilience in the first half in more challenging markets. Growth in our developing markets was strong and our Healthcare business was also solidly ahead, while in our mature markets we remained disciplined on price and continued to invest in our go-to-market capabilities. Grupo Mabe has performed well, and in just four months has helped to increase the proportion of Ontex revenue generated outside of Western Europe in the first half to 46%. The integration is proceeding well and we are starting to capture the expected synergies. In the second half, as we roll off the impact of some contract gains and losses in Mature Markets, we expect to deliver Group revenue growth in line with our mid term model.”

The Babycare category revenue was 20.1% higher on a reported basis in H1 2016 including Grupo Mabe sales from March to June 2016, and down 2.7% on a LFL basis. Sales of babycare products were well ahead of last year in developing markets, however this could not offset a decrease in developed markets.

Revenue for the Femcare category rose 2.7% on a reported basis in H1 2016 including four months of Grupo Mabe sales, and was essentially stable at -0.2% on a LFL basis. Most of its femcare sales are in Western Europe through retailer brands, where Ontex’s revenue was ahead of the market, which was slightly down year-on-year.

H1 2016 Adult Inco category revenue was up 5.7% on a reported basis including four months of Grupo Mabe sales, and on a LFL basis grew 4.2%. On a LFL basis, sales in institutional channels were slightly higher, while retail sales grew 13% yoy.